Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지

Interstitial Lung Disease

간질성 폐질환

  • Chung, Man Pyo (Division of Pulmonary and Critical Care Medicine, Dpartment of Medicine Sansung Medical Center Sungkyunkwan University School of Medicine)
  • 정만표 (성균관대학교 의과대학 삼성서울병원 호흡기내과)
  • Published : 2006.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Bajwa EK, Ayas NT, Schulzer M, Mak E, Ryu JH, Malhotra A. Interferon-1b therapy in idiopathic pulmonary fibrosis: a mata-analysis. Chest 2005:128: 203-6 https://doi.org/10.1378/chest.128.1.203
  2. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004:350:125-33. https://doi.org/10.1056/NEJMoa030511
  3. Antoniou KM, Nicholson AG, Dimadi M, Malagari K, Latsi P, Rapti A, et al. Long-term clinical effect of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis. Eur Resp J 2006:28:496-504 https://doi.org/10.1183/09031936.06.00032605
  4. Demedts M, Behr J, Buhl R, Costabel U, Dekhuijen R, Jansen HM, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005; 353:2229-42 https://doi.org/10.1056/NEJMoa042976
  5. Behr J, Maier K, Degenkolb B, Krombach F, Vogelmeier C. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Am J Respir Crit Care Med 1997:156:1897-901 https://doi.org/10.1164/ajrccm.156.6.9706065
  6. Date H, Tanimoto Y, Goto K, Yamadori I, Aoe M, Sano Y, et al. A new treatment strategy for advanced idiopathic interstitial pneumonia: living-donor lobar lung transplantation. Chst 2005:128:1364-70
  7. Jegal Y, Kim DS, Shim TS, Lim C, Lee SD, Koh Y, et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005:171:639-44 https://doi.org/10.1164/rccm.200403-331OC
  8. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005:142:963-7 https://doi.org/10.1001/archinte.142.5.963
  9. Selman M, Pardo A, Barrera L, Estrada A, Watson SR, Wilson K, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006:173:188-98 https://doi.org/10.1164/rccm.200504-644OC